Candidate SNP analyses integrated with mRNA expression and hormone levels reveal influence on mammographic density and breast cancer risk
暂无分享,去创建一个
I. Gram | V. Kristensen | G. Ursin | M. Biong | V. Dumeaux | Å. Helland | M. Suderman | P. Berg | B. Kulle | VD. Haakensen | P. Berg | M. H Hallett | A. Børresen-Dale | V. Drageset | A. Borresen-Dale | M. Hallet | Margarethe Biong
[1] E. Burnside,et al. Circulating Sex Hormones and Mammographic Breast Density among Postmenopausal Women , 2011, Hormones & cancer.
[2] Peter Kraft,et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk , 2011, Nature Genetics.
[3] P. Zhou,et al. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis , 2011, Breast Cancer Research and Treatment.
[4] T. Nakayama,et al. Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure. , 2010, European journal of endocrinology.
[5] Torben Lüders,et al. Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density , 2010, Breast Cancer Research.
[6] M. Kampa,et al. Testosterone membrane‐initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR , 2010, Molecular oncology.
[7] A. Maxwell,et al. Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line , 2010, Molecular Cancer Research.
[8] S. Sundaram,et al. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck , 2010, Journal of Biomedical Science.
[9] H. Ozer,et al. PHF10 Is Required for Cell Proliferation in Normal and SV40-Immortalized Human Fibroblast Cells , 2010, Cytogenetic and Genome Research.
[10] A. Spurdle,et al. The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[11] N. Schork,et al. The Relative Importance of Genetics and Environment on Mammographic Density , 2009, Cancer Epidemiology Biomarkers & Prevention.
[12] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[13] H. Prentice-Dunn,et al. Palladin Contributes to Invasive Motility in Human Breast Cancer Cells , 2008, Oncogene.
[14] B. Fridley,et al. Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders. , 2008, Blood.
[15] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[16] I. Gram,et al. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women , 2007, International journal of cancer.
[17] I. Delgado-Enciso,et al. Matrix Metalloproteinase-2 Promoter Polymorphism Is Associated with Breast Cancer in a Mexican Population , 2007, Gynecologic and Obstetric Investigation.
[18] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.
[19] John L Hopper,et al. Mammographic Density and Candidate Gene Variants: A Twins and Sisters Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[20] W. Jelkmann. Erythropoietin after a century of research: younger than ever , 2007, European journal of haematology.
[21] Xavier Estivill,et al. SNPassoc: an R package to perform whole genome association studies , 2007, Bioinform..
[22] Y. Furuichi,et al. Modulation of the expression of bloom helicase by estrogenic agents. , 2007, Biological & pharmaceutical bulletin.
[23] K. Hemminki,et al. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression , 2007, Breast Cancer Research and Treatment.
[24] W. Wells,et al. Spot 14: A marker of aggressive breast cancer and a potential therapeutic target. , 2006, Endocrinology.
[25] V. McCormack,et al. Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.
[26] Jun Yao,et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. , 2006, Cancer research.
[27] N. Boyd,et al. Pituitary Growth Hormone and Growth Hormone–Releasing Hormone Receptor Genes and Associations with Mammographic Measures and Serum Growth Hormone , 2005, Cancer Epidemiology Biomarkers & Prevention.
[28] M. Pike,et al. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. , 2005, American journal of epidemiology.
[29] G. Colditz,et al. Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women , 2005, Cancer Epidemiology Biomarkers & Prevention.
[30] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[31] A. Paterson,et al. Mammographic breast density as an intermediate phenotype for breast cancer. , 2005, The Lancet. Oncology.
[32] M. Pike,et al. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue , 2005, Breast Cancer Research.
[33] U. Weidle,et al. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays , 2005, British Journal of Cancer.
[34] A. Uitterlinden,et al. Polymorphisms in the Estrogen Receptor α Gene and Mammographic Density , 2005, Cancer Epidemiology Biomarkers & Prevention.
[35] J. Russo,et al. Breast differentiation and its implication in cancer prevention. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Dean Y. Li,et al. The axonal attractant Netrin-1 is an angiogenic factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Yaffe,et al. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[38] Navin Parekh,et al. Effects of mammographic density and benign breast disease on breast cancer risk (United States) , 2001, Cancer Causes & Control.
[39] T. Sellers,et al. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) , 2000, Cancer Causes & Control.
[40] D. Hunter,et al. Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density , 2004, Breast Cancer Research and Treatment.
[41] Jennifer A Harvey,et al. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. , 2004, Radiology.
[42] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..
[43] Karla Kerlikowske,et al. Mammographic breast density and family history of breast cancer. , 2003, Journal of the National Cancer Institute.
[44] N F Boyd,et al. The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.
[45] David Tritchler,et al. Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.
[46] D. V. Berg,et al. Genetic determinants of mammographic density , 2002, Breast Cancer Research.
[47] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[48] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[49] T. Südhof,et al. SCAMP1 Function in Endocytosis* , 2000, Journal of Biological Chemistry.
[50] J. Foekens,et al. Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment. , 2000, Journal of the National Cancer Institute.
[51] M A Astrahan,et al. The detection of changes in mammographic densities. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[52] C. Byrne,et al. Studying mammographic density: implications for understanding breast cancer. , 1997, Journal of the National Cancer Institute.
[53] J. Wolfe,et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.
[54] A. Oza,et al. Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.
[55] B. Dutrillaux,et al. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. , 1990, Cancer genetics and cytogenetics.
[56] A. Morrison,et al. Height and weight, mammographic features of breast tissue, and breast cancer risk. , 1984, American journal of epidemiology.
[57] F Merletti,et al. The relation of mammographic features of the breast to breast cancer risk factors. , 1982, American journal of epidemiology.
[58] J. Adams,et al. Dehydroepiandrosterone sulfotransferase as a possible shunt for the control of steroid metabolism in human mammary carcinoma. , 1977, Cancer research.
[59] J. Adams,et al. Steroid metabolism by human mammary carcinoma , 1976, Steroids.